/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

ENDRA Life Sciences Inc Share Price Today: Live Updates & Key Insights

ENDRA Life Sciences Inc share price today is $3.3, up -3.25%. The stock opened at $3.6557 against the previous close of $3.38, with an intraday high of $3.6557 and low of $3.4.

ENDRA Life Sciences Inc Share Price Chart

style
pb-0

ENDRA Life Sciences Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

ENDRA Life Sciences Inc Share Price Performance

$3.3 -0.0325(-3.25%) NDRA at 13 Mar 2026 02:26 PM Diagnostics & Research
Lowest Today 3.4
Highest Today 3.6557
Today’s Open 3.6557
Prev. Close 3.38
52 Week High 11.96
52 Week Low 2.90
Day’s Range: Low 3.4 High 3.6557
52-Week Range: Low 2.90 High 11.96
1 day return -
1 Week return +7.14
1 month return +2.56
3 month return -30.76
6 month return -28.85
1 year return -12.19
3 year return -1.63
5 year return -93.43
10 year return -

ENDRA Life Sciences Inc Institutional Holdings

Vanguard Group Inc 1.11

DRW Securities, LLC 1.09

Fidelity Extended Market Index 0.44

Vanguard Institutional Extnd Mkt Idx Tr 0.24

Fidelity Series Total Market Index 0.14

Spartan Total Market Index Pool G 0.06

Tower Research Capital LLC 0.02

UBS Group AG 0.01

Northwestern Mutual Wealth Management Co 0.00

Bank of America Corp 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

ENDRA Life Sciences Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

ENDRA Life Sciences Inc Fundamentals

Market Cap 5.06 M

PB Ratio 23.0048

PE Ratio 0.1732

Enterprise Value 3.67 M

Total Assets 4.45 M

Volume 12420

ENDRA Life Sciences Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:0 0.0M, FY20:null 0.0M, FY19:0 0.0M

Annual Net worth FY23:-11890310 -11.9M, FY22:-13200625 -13.2M, FY21:-11189705 -11.2M, FY20:-11966769 -12.0M, FY19:-15554530 -15.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:211600 0.2M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-39389 -0.0M, Q2/2025:-32790 -0.0M, Q1/2025:-45583 -0.0M, Q3/2024:null 0.0M, Q2/2024:-50124 -0.1M

Quarterly Net worth Q3/2025:-1595959 -1.6M, Q2/2025:-1225912 -1.2M, Q1/2025:-1036330 -1.0M, Q3/2024:-2354090 -2.4M, Q2/2024:-2229153 -2.2M

About ENDRA Life Sciences Inc & investment objective

Company Information ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source comprising radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Organisation Diagnostics & Research

Employees 21

Industry Diagnostics & Research

CEO Mr. Alexander Y. Tokman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow